Pharmaco- and Device epidemiology, University of Oxford

We are involved in a number of international Real World Evidence studies exploring the conditions of use,risk,benefit,and cost-effectiveness of licensed drugs and medical devices in 'real world' routine practice conditions. We have extensive expertise in the analysis and interpretation of large international databases,and in federated analytics built on the OMOP Common Data Model. Our team is one of the main subcontractors for the DARWIN EU Coordination Centre,where we are involved in the development of analytical pipelines and the leadership of and participation in multiple studies https://darwin-eu.org/about/coordination-centre